Literature DB >> 7398743

Environmental influences on human foetal and placental xenobiotic metabolism.

O Pelkonen.   

Abstract

The human foetus is more capable of metabolizing xenobiotics than foetuses of common laboratory animal species. However, xenobiotic metabolism in animal foetuses is inducible by the exposure of the mother to various inducers during late pregnancy. Xenobiotic metabolism in neonates is more easily inducible than in foetal animals. With respect to the human foetus at mid-pregnancy, the hepatic enzyme systems do not seem to be readily inducible by exoaenous inducers, whereas the placental monooxygenase system is almost totaly dependent on maternal cigarette smoking. In the human newborn, indirect evidence points to the possibility of induction by potential inducers. The ontogenetic development of xenobiotic metabolism is probably regulated by endogenous hormones. It is possible that environmental factors may effect these normal regulatory and "imprinting" phenomena and thus lead to permanent disturbances in xenobiotic metabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398743     DOI: 10.1007/bf00561474

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  62 in total

1.  Enzymic differentiation of human liver: comparison with the rat model.

Authors:  O Greengard
Journal:  Pediatr Res       Date:  1977-05       Impact factor: 3.756

Review 2.  Developmental aspects of drug conjugation, with special reference to glucuronidation.

Authors:  G J Dutton
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

Review 3.  Developmental pharmacology: a review of its application to clinical and basic science.

Authors:  J T Wilson
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

4.  Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy.

Authors:  H M Maurer; J A Wolff; M Finster; P J Poppers; E Pantuck; R Kuntzman; A H Conney
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

5.  Metabolism of hexobarbital and zoxazolamine by placentae and fetal liver supernatant fraction and response to phenobarbital and chlordane treatment.

Authors:  R L Dixon; V J Willson
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-04

6.  Microsomal N-demethylase activity in developing rat liver after administration of 3-methylcholanthrene.

Authors:  E Bresnick; J G Stevenson
Journal:  Biochem Pharmacol       Date:  1968-09       Impact factor: 5.858

7.  Induction of hepatic mono-oxygenase systems in fetal and neonatal rats with phenobarbital, polycylic hydrocarbons and other xenobiotics.

Authors:  T M Guenthner; G J Mannering
Journal:  Biochem Pharmacol       Date:  1977-04-01       Impact factor: 5.858

8.  Stimulation of hepatic and renal mixed-function oxidase in developing rats by polybrominated biphenyls.

Authors:  K M McCormack; S Z Cagen; D E Rickert; J E Gibson; J G Dent
Journal:  Drug Metab Dispos       Date:  1979 Sep-Oct       Impact factor: 3.922

9.  The influence of phenobarbitone on maternal and perinatal hepatic drug-metabolizing enzymes in the rat.

Authors:  J U Bell; M M Hansell; D J Ecobichon
Journal:  Can J Physiol Pharmacol       Date:  1975-12       Impact factor: 2.273

10.  Aryl hydrocarbon hydroxylase activity and microsomal cytochrome content of human fetal tissues.

Authors:  A B Rifkind; L Tseng; M B Hirsch; N H Lauersen
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

View more
  2 in total

Review 1.  Chemical carcinogenesis: a biologic perspective.

Authors:  E Farber
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

2.  Metabolism of propranolol in the human maternal-placental-foetal unit.

Authors:  M T Smith; I Livingstone; M J Eadie; W D Hooper; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.